This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Does the use of lapatinib increase the risk of fatigue and hepatic toxicities in patients with solid tumors? A critical literature review and meta-analysis, Expert Opinion on Drug Safety, June 2014, Informa Healthcare,
DOI: 10.1517/14740338.2014.921679.
You can read the full text:
The following have contributed to this page
